Pharmacokinetics of High-Dosage Thiopental Sodium in Patients with Cerebral Injuries
暂无分享,去创建一个
S. Urien | F. Bressolle | J. Brès | M. Duboin | H. Russo
[1] F. Bressolle,et al. High-performance liquid chromatographic assay for thiopental in human plasma. Application to pharmacokinetic studies. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[2] M. Audran,et al. Displacement of thiopental from human serum albumin by associated drugs. , 1993, Journal of pharmaceutical sciences.
[3] D R Stanski,et al. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. , 1990, Anesthesiology.
[4] S. Wrighton,et al. Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. , 1987, Archives of biochemistry and biophysics.
[5] K. Peter,et al. Thiopentalkinetik bei hochdosierter Anwendung , 1986 .
[6] D. Morgan,et al. Evaluation of Infusion Regimens for Thiopentone as a Primary Anesthetic Agent , 1986 .
[7] P. Watkins,et al. Identification of an inducible form of cytochrome P-450 in human liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Granry,et al. Thiopental Pharmacokinetics under Conditions of Long‐term Infusion , 1985, Anesthesiology.
[9] P. Duvaldestin,et al. Thiopentone pharmacokinetics in patients with chronic alcoholism. , 1984, British journal of anaesthesia.
[10] S. Schiff,et al. High Dose Barbiturate Therapy in Neurosurgery and Intensive Care , 1984, Neurosurgery.
[11] F. Andreasen,et al. Pharmacokinetics and Pharmacodynamics of Thiopental in Patients Undergoing Renal Transplantation , 1983, Acta anaesthesiologica Scandinavica.
[12] D R Stanski,et al. A Model for Studying Depth of Anesthesia and Acute Tolerance to Thiopental , 1983, Anesthesiology.
[13] P. G. Burch,et al. Pharmacokinetics of Methohexital and Thiopental in Surgical Patients , 1983, Anesthesiology.
[14] M. Farinotti,et al. Thiopental Pharmacokinetics in Patients with Cirrhosis , 1983, Anesthesiology.
[15] P. G. Burch,et al. The Role of Metabolism and Protein Binding in Thiopental Anesthesia , 1983, Anesthesiology.
[16] T. Hassard,et al. The ‘induction’ dose of thiopentone , 1982, Anaesthesia.
[17] P. G. Burch,et al. Decreased protein binding and thiopental kinetics , 1982, Clinical pharmacology and therapeutics.
[18] D. Perrier,et al. Thiopental Disposition in Lean and Obese Patients Undergoing Surgery , 1982, Anesthesiology.
[19] F. Andreasen,et al. Pharmacokinetics and pharmacodynamics of thiopentone , 1982, Anaesthesia.
[20] D. Perrier,et al. Thiopental disposition as a function of age in female patients undergoing surgery. , 1982 .
[21] F. Andreasen,et al. Influence of age and sex on the pharmacokinetics of thiopentone. , 1981, British journal of anaesthesia.
[22] J. Paull,et al. Pharmacokinetics and plasma binding of thiopental. I: Studies in surgical patients. , 1981, Anesthesiology.
[23] D. Morgan,et al. Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section. , 1981, Anesthesiology.
[24] F. Andreasen,et al. Pharmacokinetics of Thiopental in Caesarian Section , 1981, Acta anaesthesiologica Scandinavica.
[25] M. Partinen,et al. Status epilepticus treated by barbiturate anaesthesia with continuous monitoring of cerebral function. , 1981, British medical journal.
[26] J. Dundee,et al. Another look at acute tolerance to thiopentone. , 1980, British journal of anaesthesia.
[27] F. Andreasen,et al. Pharmacokinetics of thiopentone in a group of young women and a group of young men. , 1980, British journal of anaesthesia.
[28] D. Stanski,et al. Pharmacokinetics of high-dose thiopental used in cerebral resuscitation. , 1980, Anesthesiology.
[29] D. Perrier,et al. Pharmacokinetic Properties of Thiopental in Two Patients Treated for Uncontrollable Seizures , 1979, Epilepsia.
[30] M. Ghoneim,et al. Pharmacokinetics of thiopentone: effects of enflurane and nitrous oxide anaesthesia and surgery. , 1978, British journal of anaesthesia.
[31] K. Becker. Plasma Levels of Thiopental Necessary for Anesthesia , 1978, Anesthesiology.
[32] F. Andreasen,et al. Individual Variation in Response to Thiopental , 1978, Acta anaesthesiologica Scandinavica.
[33] M. Herzberg,et al. Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory. , 1977, Israel journal of medical sciences.
[34] M. Ghoneim,et al. Binding of Thiopental to Plasma Proteins: Effects on Distribution in the Brain and Heart , 1976, Anesthesiology.
[35] Grant R. Wilkinson,et al. A physiological approach to hepatic drug clearance , 1975 .
[36] J. Wagner. A safe method for rapidly achieving plasma concentration plateaus , 1974, Clinical pharmacology and therapeutics.
[37] R. K. Richards,et al. Displacement of Thiopental from Plasma Proteins by Nonsteroidal Anti-inflammatory Agents 1 , 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[38] Eric Chicken,et al. Nonparametric Statistical Methods: Hollander/Nonparametric Statistical Methods , 1973 .
[39] C. Maruffo,et al. Ultrastructure of human liver at the end of normal pregnancy. , 1971, American journal of obstetrics and gynecology.
[40] L. C. Mark,et al. Thiopental Metabolism by Human Liver in vivo and in vtro , 1965, Nature.
[41] T. Miya,et al. Stress Modification of Drug Response , 1963, Science.
[42] L. C. Mark,et al. LACK OF CORRELATION BETWEEN ELECTROENCEPHALOGRAPHIC EFFECTS AND PLASMA CONCENTRATIONS OF THIOPENTONE , 1961 .
[43] Brodie Bb. Physiological disposition and chemical fate of thiobarbiturates in the body. , 1952 .
[44] F. Bressolle,et al. Nonlinear Pharmacokinetics of High-Dose Thiopental Following Long Term Treatment , 1996 .
[45] A. Batt,et al. Les cytochromes P450 hépatiques chez l'homme , 1991 .
[46] F. Guengerich. Characterization of human microsomal cytochrome P-450 enzymes. , 1989, Annual review of pharmacology and toxicology.
[47] F. Andreasen,et al. Thiopentone sensitivity in young and elderly women. , 1983, British journal of anaesthesia.
[48] R. Swartz,et al. Effects of physical stress on the disposition of drugs eliminated by the liver in man. , 1974, The Journal of pharmacology and experimental therapeutics.